Predicta Biosciences
PrivateLast Round
Series A
Oct 1, 2025
Total Funding Raised
$28.6M
Company Overview
Predicta Biosciences operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series A round in October 2025.
Predicta Biosciences is a biotechnology company that has developed an oncology technology platform designed for cancer diagnosis and treatment, specializing in integrating multi-omics and liquid biopsy technologies.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Predicta Biosciences Comparables
Compare Predicta Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Precede | 82% | |
| One Biosciences | 80% | |
| Delfi Diagnostics | 76% |
For institutional investors. Book with your work email.
Predicta Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 1, 2025 | ||||
| Seed | Jul 16, 2024 |
For institutional investors. Book with your work email.
Predicta Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Engine Ventures | Seed, Series A |
| Binney Street Capital | Series A |
| Mass General Brigham Innovation | Series A |
| Mass General Brigham Ventures | Series A |
| BrightEdge | Seed, Series A |
| Engine Ventures | Seed, Series A |
| Time Boost Capital I LP | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2026
Grew 33% QoQ, from 15 to 20 employees.
- Apr 15, 2026
Launched GenoPredicta test kit in partnership with Tempus AI.
For institutional investors. Book with your work email.
Predicta Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Predicta Biosciences's valuation, stock price, and market status.
Is Predicta Biosciences a public or private company?
Predicta Biosciences is a private company.
What is the current stock price of Predicta Biosciences?
Predicta Biosciences is a private company, so its shares have no public market price. Caplight tracks Predicta Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Predicta Biosciences worth (valuation)?
Valuation information for Predicta Biosciences is not publicly available.
Can I buy Predicta Biosciences stock?
Predicta Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Predicta Biosciences's last funding round?
Predicta Biosciences's most recent funding round was Series A on October 1, 2025.
Who are the main investors in Predicta Biosciences?
Key investors in Predicta Biosciences include Engine Ventures, Engine Ventures.
Will Predicta Biosciences IPO soon?
No public IPO plans have been announced for Predicta Biosciences.
How can I track Predicta Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Predicta Biosciences's shares on secondary markets.